000 01533 a2200409 4500
005 20250513125044.0
264 0 _c19971009
008 199710s 0 0 eng d
022 _a0022-4804
024 7 _a10.1006/jsre.1997.5139
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSheridan, B C
245 0 0 _aPhosphodiesterase inhibition overcomes pulmonary vasomotor dysfunction in acute lung injury.
_h[electronic resource]
260 _bThe Journal of surgical research
_cAug 1997
300 _a145-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _a1-Methyl-3-isobutylxanthine
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aCalcimycin
_xpharmacology
650 0 4 _aCyclic GMP
_xphysiology
650 0 4 _aEndothelium, Vascular
_xphysiology
650 0 4 _aEndotoxins
_xtoxicity
650 0 4 _aMale
650 0 4 _aMuscle, Smooth, Vascular
_xphysiology
650 0 4 _aNitroprusside
_xpharmacology
650 0 4 _aPhosphodiesterase Inhibitors
_xpharmacology
650 0 4 _aPulmonary Artery
_xdrug effects
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aRespiratory Distress Syndrome
_xdrug therapy
650 0 4 _aVasodilation
_xdrug effects
700 1 _aMcIntyre, R C
700 1 _aMeldrum, D R
700 1 _aFullerton, D A
773 0 _tThe Journal of surgical research
_gvol. 71
_gno. 2
_gp. 145-9
856 4 0 _uhttps://doi.org/10.1006/jsre.1997.5139
_zAvailable from publisher's website
999 _c9277781
_d9277781